Giving Cells an Invisibility Cloak
The Context: Cell therapies hold enormous promise for treating many of today’s most devastating diseases, but for them to be effective, we have to ensure that...
The latest news and updates about NYSCF and our collaborators
The Context: Cell therapies hold enormous promise for treating many of today’s most devastating diseases, but for them to be effective, we have to ensure that...
In an exciting step towards a new treatment, an FDA panel has approved a therapy for sickle cell disease that employs CRISPR gene editing. The decision...
The Context: CRISPR is a powerful gene editing tool that allows scientists to make changes in the DNA of cells for research or treatment purposes. The...
News reports out of the United Kingdom detail the births of the first children who have undergone mitochondrial replacement therapy (MRT) – a technique that NYSCF...
NYSCF Principal Scientist Josephine (Josi) Wesely, PhD, was probably the only kid who showed up to her doctor’s appointments with scientific papers in hand. “I was...
The Context: Gene therapies hold a great deal of promise for treating a wide range of diseases. For the gene therapy to be effective, however, proteins...
Gene editing: you’ve likely heard of it before, but what is the science behind biomedicine’s most versatile new star? How is it used for research and...
The Context: INAD is a rare neurological disease affecting children, often referred to as a “pediatric Parkinson’s,” which is typically diagnosed between six months to three...
The Context: All our blood cells are created in the bone marrow by blood-forming stem cells, and when this process goes awry, leukemia can arise. Scientists...
Earlier this month, NYSCF hosted an intimate conversation with Interim CEO Derrick Rossi, PhD, who shared the journey of his already long and storied career in...
Even if you don’t know Derrick Rossi, PhD, you almost certainly know Moderna: the company behind mRNA vaccine technology he co-founded that is protecting millions from...
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
The American Cancer Society estimates that nearly 20,000 women will be diagnosed with ovarian cancer in 2022, and 12,000 of them will die. Survival rates have...
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
The Context: CRISPR gene editing holds a great deal of promise for correcting disease-causing mutations in humans, potentially as early as during embryonic development. However, before...
Top row: Drs. Raffaella Di Micco, Samantha Morris, José Ordovás-Montañés. Bottom row: Drs. Jiami Guo, David Schneider, John Tuthill New York, NY (October 20, 2020) – The...
The Context: Mitochondria are structures in our cells that carry their own DNA inherited only from our mothers and provide energy to help our bodies function....
The Context: To fit inside the nucleus of our cells, our DNA crumples up, forming loops and making itself compact. When certain sequences of looped DNA...
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
In a new article from the patient advocacy and research nonprofit Jordan’s Guardian Angels, NYSCF speaks about its work creating induced pluripotent stem cells from patients with Jordan’s...